Structure of rat neuronal nitric oxide synthase heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-5-(trifluoromethyl)phenethyl)-4-methylpyridin-2-amine

Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.

Residues 339 to 349 are disordered.
The N-terminal residues 297 and 298
as well as C-terminal residues 717
and 718 are not observed in density

BNOS,Constitutive NOS,NC-NOS,NOS type I,Neuronal NOS,nNOS,Peptidyl-cysteine S-nitrosylase NOS1

20-24% PEG3350, 0.1M MES
0.14-0.20M AMMONIUM ACETATE,
10% ETHYLENE GLYCOL,
30uM SDS, 5 mM GSH

National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

Nitric oxide synthase, brain (E.C.1.14.13.39)

nitric oxide synthase inhibitor complex heme enzyme, OXIDOREDUCTASE